Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ADHD: Medication or Meditation?
NL-OMON44743Active, not recruiting
- Sponsor
- University of Amsterdam
- Start
- May 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, open-label trial of methylphenidate in attention deficit hyperactivity disorder (ADHD) (2 arms), sponsored by University of Amsterdam. Primary endpoints: Attention problems and Hyperactivity and impulsivity. Started May 2014; status: active, not recruiting.
02
Drugs
methylphenidate
03
Conditions
attention deficit hyperactivity disorder (ADHD)
Beyond the preview
Go deeper on NL-OMON44743.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON44743.